 Clinical Oncology News | Expert Commentary: The Future of Ibrutinib Clinical Oncology News In addition, the US cooperative groups led by the Alliance for Clinical Trials in Oncology are currently planning a randomized study of initial therapy in older patients comparing ibrutinib alone with ibrutinib plus rituximab and bendamustine plus ... |
